QUEST DIAGNOSTICS INC (DGX) Cost of Revenue USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD and USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Quest Diagnostics Inc quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • Quest Diagnostics Inc Cost of Revenue for the quarter ending March 31, 2024 was $1.6 B, a 2.24% increase year-over-year.
  • Quest Diagnostics Inc Cost of Revenue for the twelve months ending March 31, 2024 was $6.23 B, a 2.04% decline year-over-year.
  • Quest Diagnostics Inc annual Cost of Revenue for 2023 was $6.2 B, a 3.89% decline from 2022.
  • Quest Diagnostics Inc annual Cost of Revenue for 2022 was $6.45 B, a 1.96% decline from 2021.
  • Quest Diagnostics Inc annual Cost of Revenue for 2021 was $6.58 B, a 13.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.2 B -$251 M -3.89% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $6.45 B -$129 M -1.96% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $6.58 B +$775 M +13.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $5.8 B +$767 M +15.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $5.04 B +$111 M +2.25% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $4.93 B +$207 M +4.39% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-22
2017 $4.72 B +$103 M +2.23% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-20
2016 $4.62 B -$41 M -0.88% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $4.66 B +$20 M +0.43% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-23
2014 $4.64 B +$311 M +7.19% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 $4.33 B -$39 M -0.89% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $4.37 B +$2 M +0.05% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $4.36 B +$87.5 M +2.05% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-18
2010 $4.28 B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.